Fernández-Tomé María del Carmen, Speziale Emir H S, Sterin-Speziale Norma B
Departamento de Ciencias Biológicas, Cátedra de Biología Celular e Histología, Facultad de Farmacia y Bioquímica, Universidad de Buenos Aires, IQUIFIB-CONICET, Junín 956, 1er piso (1113), Buenos Aires, Argentina.
Biochim Biophys Acta. 2002 Jul 11;1583(2):185-94. doi: 10.1016/s1388-1981(02)00208-1.
Phosphatidylcholine (PC) is the most abundant phospholipid in mammalian cell membranes. Several lines of evidence support that PC homeostasis is preserved by the equilibrium between PC biosynthetic enzymes and phospholipases catabolic activities. We have previously shown that papillary synthesis of PC depends on prostaglandins (PGs) that modulate biosynthetic enzymes. In papillary tissue, under bradikynin stimulus, arachidonic acid (AA) mobilization (the substrate for PG synthesis) requires a previous phospholipase C (PLC) activation. Thus, in the present work, we study the possible involvement of PLC in PC biosynthesis and its relationship with PG biosynthetic pathway on the maintenance of phospholipid renewal in papillary membranes; we also evaluated the relevance of CDP-choline pathway enzymes compartmentalization. To this end, neomycin, U-73122 and dibutiryl cyclic AMP, reported as PLC inhibitors, were used to study PC synthesis in rat renal papilla. All the PLC inhibitors assayed impaired PC synthesis. PG synthesis was also blocked by PLC inhibitors without affecting cyclooxygenase activity, indicating a metabolic connection between both pathways. However, we found that PC biosynthesis decrease in the presence of PLC inhibitors was not a consequence of PG decreased synthesis, suggesting that basal PLC activity and PGs exert their effect on different targets of PC biosynthetic pathway. The study of PC biosynthetic enzymes showed that PLC inhibitors affect CTP:phosphocholine cytidylyltransferase (CCT) activity while PGD(2) operates on CDP-choline:1,2-diacylglycerol cholinephosphotransferase (CPT), both activities associated to papillary enriched-nuclei fraction. The present results suggest that renal papillary PC synthesis is a highly regulated process under basal conditions. Such regulation might occur at least at two different levels of the CDP-choline pathway: on the one hand, PLC operates on CCT activity; on the other, while PGs regulate CPT activity.
磷脂酰胆碱(PC)是哺乳动物细胞膜中含量最丰富的磷脂。多项证据支持,PC的稳态是通过PC生物合成酶与磷脂酶分解代谢活性之间的平衡来维持的。我们之前已经表明,PC的乳头合成依赖于调节生物合成酶的前列腺素(PGs)。在乳头组织中,在缓激肽刺激下,花生四烯酸(AA)的动员(PG合成的底物)需要先前的磷脂酶C(PLC)激活。因此,在本研究中,我们研究了PLC在PC生物合成中的可能作用及其与PG生物合成途径在维持乳头细胞膜磷脂更新中的关系;我们还评估了CDP-胆碱途径酶区室化的相关性。为此,将已报道为PLC抑制剂的新霉素、U-73122和二丁酰环磷酸腺苷用于研究大鼠肾乳头中的PC合成。所有检测的PLC抑制剂均损害了PC合成。PG合成也被PLC抑制剂阻断,而不影响环氧化酶活性,这表明两条途径之间存在代谢联系。然而,我们发现,在存在PLC抑制剂的情况下PC生物合成的减少不是PG合成减少的结果,这表明基础PLC活性和PGs对PC生物合成途径的不同靶点发挥作用。对PC生物合成酶的研究表明,PLC抑制剂影响CTP:磷酸胆碱胞苷转移酶(CCT)的活性,而PGD(2)作用于CDP-胆碱:1,2-二酰基甘油胆碱磷酸转移酶(CPT),这两种活性都与乳头富集核部分相关。目前的结果表明,肾乳头PC合成在基础条件下是一个高度调节的过程。这种调节可能至少发生在CDP-胆碱途径的两个不同水平:一方面,PLC作用于CCT活性;另一方面,PGs调节CPT活性。